CONNEQT Health Limited

—As of Sun 8 Nov 2026, 12:00 UTC

ASX:CQTHealthcare

Country Australia

PE (Fwd) •••

TSR 10Y CAGR (40.87%)

Div yield —

ROE (5355.88%)

Medical Devices

Beta (5Y) 0.38

PE TTM —

TSR TTM (88.24%)

Mkt cap A$3.691M

ROIC (160.78%)

SE Grade™

—

Value

Quality

Moat

Consensus

Reference

$0.0046

14.64%

(79.90%)

Hold 8|2|1|5|3

TTM

FYE 30 Jun AUD

FY2017

FY2018

FY2019

FY2020

FY2021

FY2022

FY2023

FY2024

FY2025

FY2026

FY2027E

Trend

5Y

10Y

Peers

0.665

Revenue$M

0.524

0.534

0.554

0.587

0.595

0.621

0.651

0.664

0.686

0.714

0.691

3.71%

3.27%

88

21.43

Revenue growth%

10.75

12.07

12.83

11.46

11.46

10.21

10.64

8.20

7.96

8.25

18.36

8.25

10.70

25

25.94

Gross margin%

24.92

26.34

24.56

23.48

21.13

21.69

20.56

18.78

20.78

19.32

11.01

20.56

21.41

66

19.32

Operating margin%

5.61

5.91

7.82

10.02

12.33

15.26

17.80

17.56

16.54

17.01

18.13

17.01

13.79

37

24.61

Net margin%

11.18

10.75

9.20

11.44

14.06

11.59

11.75

11.97

13.85

15.79

4.83

11.97

11.67

19

35.36

P/E ratio (avg)x

43.77

41.46

45.73

45.99

49.51

50.40

54.71

56.00

64.89

75.42

23.82

56.00

49.95

39

26.30

EV/EBITx

24.81

28.65

30.74

34.15

39.31

41.64

43.11

47.15

53.31

60.32

18.12

47.15

40.47

38

16.52

FCF yield (avg)%

14.50

17.17

15.44

17.22

16.09

18.73

19.23

20.95

20.72

20.81

11.25

20.72

17.97

79

4.91

FCF margin%

10.44

12.99

14.67

15.97

13.33

10.58

7.91

10.07

11.36

10.41

26.78

10.41

10.97

40

1.571

FCF / Net incomex

0.341

0.312

0.268

0.233

0.215

0.231

0.240

0.235

0.219

0.193

1.027

0.231

0.234

64

5.91

ROIC%

10.44

13.14

10.93

8.54

7.58

10.24

9.57

6.74

8.62

7.84

19.45

8.62

9.10

14

9.62

Return on equity%

27.05

28.37

29.10

29.81

32.06

34.75

34.38

33.56

31.23

33.81

17.61

33.81

31.64

53

18.40

Return on assets%

21.85

24.08

24.90

23.69

24.95

25.90

25.89

24.45

25.12

25.30

18.44

25.30

24.93

66

—

EPS$

—

—

—

—

—

—

—

—

—

—

—

4.45%

1.41%

—

3.38

EPS growth%

6.16

3.88

3.93

3.63

6.18

7.80

6.68

7.34

4.62

4.79

29.99

6.68

5.47

54

—

Bookvalue per sh$

—

—

—

—

—

—

—

—

—

—

—

3.08%

0.11%

—

—

FCF per share$

—

—

—

—

—

—

—

—

—

—

—

(1.71%)

(1.32%)

—

—

Dividend per sh$

—

—

—

—

—

—

—

—

—

—

—

2.68%

5.13%

—

15.92

Div yield (avg)%

9.83

9.66

9.04

7.68

5.74

2.91

0.41

2.52

4.07

4.32

15.70

2.91

5.03

58

15.47

Payout ratio%

18.80

19.83

16.95

18.77

16.93

16.82

17.10

15.75

15.06

13.58

26.26

15.75

16.94

29

0.950

Shares (diluted)B

1.257

1.256

1.181

1.193

1.157

1.099

1.184

1.315

1.433

1.389

0.899

3.73%

1.55%

50

19.78

Buyback yield%

0.40

1.26

3.95

3.65

3.67

5.41

2.81

1.98

0.61

3.13

14.47

2.81

2.97

10

0.740

D/E ratiox

1.210

1.320

1.338

1.374

1.373

1.622

1.727

1.942

1.937

2.261

0.403

1.937

1.498

20

0.178

Enterprise value$M

0.681

0.751

0.767

0.717

0.733

0.735

0.778

0.864

0.912

0.856

0.356

3.15%

2.58%

18

0.687

LT debt$M

0.953

1.095

1.077

1.021

1.066

1.202

1.248

1.160

1.274

1.204

0.812

2.47%

1.95%

35

Peers (US$2.535M)

Cap (US$)

PE

ImpediMed Limited

7.546M

—

Adherium Limited

2.300M

—

2.144M

—

INVO Fertility, Inc.

2.553M

—

Capital

TTM

5Y

10Y

Leveragex

0.385

0.186

0.143

EBIT/Intx

1.069

0.288

0.256

Own earn%

32.22

79.72

92.16

Sh yield%

35.69

4.68

8.87

Owners

Insiders/Inst%

1.61

67.55

Short interest%

4.86

SBC / revenue%

2.30

Record

10Y

Profitable years

10/10

Revenue growth years

10/10

EPS growth years

10/10

Dividend streakyrs

5

Op margin range%

6–18

$1 testx

—

Incr. ROIC%

5

Growth vs revenue

Latest

Trend

10Y CAGR

Rel growth

Revenue

$0.714M

3.27%

1.00×

Cost of revenue

$0.372M

3.25%

1.00×

Operating expenses

$0.144M

2.58%

0.93×